Skip to content

Lumexa Imaging Holdings, Inc. LMRI Intersegments Eliminations — Adjusted EBITDA From Continuing Operations

Similar metrics at other companies

Cleveland-Cliffs logo
CLFEliminations — Adjusted EBITDA
$0
DCH
DCHCorporate and Eliminations — Segment adjusted EBITDA
$0
Peabody Energy logo
BTUTotal Segment Excluding Corporate and Other Operating Segment — Segment Adjusted EBITDA excluding corporate and other segment
$103M-38.2%
Jones Lang LaSalle logo
JLLOther Operating Segment — Adjusted EBITDA
-$800K-133%
Custom Truck One Source logo
CTOSTotal Segments — Adjusted EBITDA
$138.2M+39.4%
Hillman Solutions Corp. logo
HLMNSegment Adjusted EBITDA
$68.83M+13.9%

Other financials

Income statement

See full
Revenue$252.5M+3.1%
Operating income$19.4M-24.0%
Net income$1.7M+122%
EPS (diluted)$0.02+118%

Balance sheet

See full
Cash & equivalents$51.2M
Total debt$965.8M
Total equity$599.6M+272%
Total assets$1.8B

Cash flow

See full
Operating cash flow$2.9M+121%
CapEx$5.3M+431%
Free cash flow-$2.4M+84.1%

Valuation

See full
Market cap$958.89M-42.0%
Enterprise value$1.87B

Returns & leverage

See full
Debt / equity1.6×
Current ratio1.4×

Where this comes from

Reported directly by Lumexa Imaging Holdings, Inc. in its filing.

Tagged under the XBRL concept lmri:AdjustedEBITDAFromContinuingOperations.

The official record: Lumexa Imaging Holdings, Inc. ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lumexa Imaging Holdings, Inc. 's intersegments eliminations — adjusted ebitda from continuing operations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lumexa Imaging Holdings, Inc. 's intersegments eliminations — adjusted EBITDA from continuing operations?
Lumexa Imaging Holdings, Inc. (LMRI) reported intersegments eliminations — adjusted EBITDA from continuing operations of $0 in Q1 2026.
What does intersegments eliminations — adjusted EBITDA from continuing operations mean?
This metric represents the elimination of Adjusted EBITDA generated from transactions between internal business segments to avoid inflating consolidated profitability. It removes the impact of internal markups or service fees charged between imaging centers or corporate divisions. By isolating these eliminations, investors can better assess the true operational profitability of the company's external diagnostic services.